Oppenheimer Initiates Coverage On Kestra Medical Techs with Perform Rating

Benzinga Newsdesk www.benzinga.com Positive 62.5%

Neg 0% Neu 0% Pos 62.5%

Oppenheimer analyst Suraj Kalia initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Perform rating.

Comments

No comments yet. Be the first!